Pourabhari Langroudi Ashkan, Shokri Varniab Zahra, Nabavizadeh Behnam, Neishabouri Afarin, Kajbafzadeh Abdol-Mohammad
Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran.
J Pediatr Urol. 2023 Jun;19(3):321.e1-321.e7. doi: 10.1016/j.jpurol.2023.02.017. Epub 2023 Feb 26.
There are various treatment options for symptomatic bladder diverticulum, including robotic-assisted laparoscopic bladder diverticulectomy, open and endoscopic techniques. But, to date, the optimal surgical technique remains unclear.
To present the preliminary long-term follow-up results of a novel technique of dextranomer/hyaluronic acid copolymer (Deflux) plus autologous blood injection for correction of hutch diverticulum in patients with concomitant vesicoureteral reflux (VUR).
We retrospectively reviewed four patients who had hutch diverticulum with concomitant VUR and had undergone submucosal Deflux following autologous blood injection. Patients with neurogenic bladder, posterior urethral valve, or voiding dysfunction were excluded from the study. Success was defined as the resolution of the diverticulum, hydronephrosis, and hydroureter on ultrasonography at a 3-month follow-up and long-term symptom-free period.
Four patients with hutch diverticula were included. The median age at the time of surgery was 6.1 (range 3-8) years. Three of them had unilateral VUR, and one had bilateral VUR. During the procedure, a mean of 0.625 ml Deflux plus a mean of 1.25 ml autologous blood were injected submucosally for correction of VUR. Additionally, a mean of 1.62 ml Deflux plus a mean of 1.75 ml autologous blood were injected submucosally to occlude the diverticulum. The median follow-up was 4.6 (range 4-8) years. This method had excellent success in all patients in the current study with no postoperative complications such as febrile urinary tract infection, or diverticulum, hydroureter, or hydronephrosis in follow-up ultrasounds.
Submucosal injection of Deflux plus autologous blood injection can be a successful endoscopic intervention for treatments of hutch diverticulum in patients with concomitant VUR. Deflux injection can be a simple and cost-effective technique.
对于有症状的膀胱憩室,有多种治疗选择,包括机器人辅助腹腔镜膀胱憩室切除术、开放性和内镜技术。但迄今为止,最佳手术技术仍不清楚。
介绍一种新的治疗方法,即葡聚糖/透明质酸共聚物(Deflux)联合自体血注射治疗合并膀胱输尿管反流(VUR)的 Hutch 憩室的初步长期随访结果。
我们回顾性分析了 4 例合并 VUR 的 Hutch 憩室患者,在接受自体血注射后行黏膜下 Deflux 治疗。患有神经性膀胱、后尿道瓣膜或排尿功能障碍的患者被排除在研究之外。成功定义为 3 个月随访时超声检查憩室、肾积水和输尿管扩张消失,以及长期无症状。
纳入 4 例 Hutch 憩室患者,手术时的中位年龄为 6.1 岁(范围 3-8 岁)。其中 3 例为单侧 VUR,1 例为双侧 VUR。手术过程中,黏膜下注射平均 0.625ml Deflux 和平均 1.25ml 自体血以矫正 VUR。此外,黏膜下注射平均 1.62ml Deflux 和平均 1.75ml 自体血以闭塞憩室。中位随访时间为 4.6 年(范围 4-8 年)。本研究中所有患者的方法均取得了极好的成功,术后无发热性尿路感染或随访超声检查发现憩室、输尿管扩张或肾积水等并发症。
黏膜下注射 Deflux 联合自体血注射可作为治疗合并 VUR 的 Hutch 憩室的成功内镜干预措施。Deflux 注射是一种简单且具有成本效益的技术。